Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$2.65 - $3.92 $27,302 - $40,387
-10,303 Reduced 48.98%
10,734 $33,000
Q1 2024

Apr 29, 2024

SELL
$2.59 - $4.65 $7,972 - $14,312
-3,078 Reduced 12.76%
21,037 $73,000
Q4 2023

Feb 07, 2024

BUY
$1.54 - $3.37 $1,750 - $3,831
1,137 Added 4.95%
24,115 $73,000
Q3 2023

Nov 02, 2023

BUY
$1.5 - $3.75 $2,914 - $7,286
1,943 Added 9.24%
22,978 $43,000
Q2 2023

Aug 07, 2023

BUY
$2.21 - $4.43 $6,236 - $12,501
2,822 Added 15.49%
21,035 $58,000
Q1 2023

May 09, 2023

SELL
$3.81 - $6.76 $5,132 - $9,105
-1,347 Reduced 6.89%
18,213 $75,000
Q4 2022

Feb 09, 2023

BUY
$4.26 - $6.84 $13,274 - $21,313
3,116 Added 18.95%
19,560 $91,000
Q3 2022

Nov 09, 2022

SELL
$6.06 - $12.86 $2,205 - $4,681
-364 Reduced 2.17%
16,444 $100,000
Q2 2022

Aug 10, 2022

BUY
$8.35 - $21.89 $48,329 - $126,699
5,788 Added 52.52%
16,808 $175,000
Q1 2022

May 09, 2022

SELL
$16.97 - $31.93 $118,060 - $222,137
-6,957 Reduced 38.7%
11,020 $227,000
Q4 2021

Feb 09, 2022

SELL
$25.61 - $41.78 $186,389 - $304,074
-7,278 Reduced 28.82%
17,977 $562,000
Q3 2021

Nov 09, 2021

BUY
$19.65 - $27.99 $18,765 - $26,730
955 Added 3.93%
25,255 $588,000
Q2 2021

Aug 10, 2021

BUY
$17.48 - $25.46 $209,620 - $305,316
11,992 Added 97.43%
24,300 $550,000
Q1 2021

May 10, 2021

SELL
$18.08 - $28.8 $27,788 - $44,265
-1,537 Reduced 11.1%
12,308 $282,000
Q4 2020

Feb 08, 2021

BUY
$11.7 - $23.41 $161,986 - $324,111
13,845 New
13,845 $302,000
Q4 2018

Feb 14, 2019

SELL
$14.06 - $22.57 $145,324 - $233,283
-10,336 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$13.35 - $19.1 $137,985 - $197,417
10,336 New
10,336 $177,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $335M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.